Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
暂无分享,去创建一个
M. Sorror | M. Maris | R. Storb | B. Sandmaier | D. Maloney | B. Storer | R. Schrier | P. Mcsweeney | C. Parikh | R. Diaconescu
[1] C. Flowers,et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. , 2004, Blood.
[2] C. Flowers,et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. , 2004, Blood.
[3] M. Maris,et al. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. , 2004, Journal of the American Society of Nephrology : JASN.
[4] L. Bachmann,et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.
[5] C. O'connor,et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. , 2004, American heart journal.
[6] M. Maris,et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. , 2003, Experimental hematology.
[7] S. Heimfeld,et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. , 2003, Blood.
[8] M. Maris,et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. , 2003, Blood.
[9] L. Cantley,et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. , 2003, The Journal of clinical investigation.
[10] K. Kelly. Distant effects of experimental renal ischemia/reperfusion injury. , 2003, Journal of the American Society of Nephrology : JASN.
[11] M. Maris,et al. Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission , 2003, British journal of haematology.
[12] E. Shpall,et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. , 2002, Kidney international.
[13] M. Dorval,et al. Acute Renal Failure in Bone Marrow Transplant Patients Admitted to the Intensive Care Unit , 2002, Nephron.
[14] M. Maris,et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. , 2002, Blood.
[15] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] A. Levey,et al. Prediction equations to estimate glomerular filtration rate: an update , 2001, Current opinion in nephrology and hypertension.
[17] J. Radich,et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. , 2001, Blood.
[18] M. Boeckh,et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. , 2000, Blood.
[19] M. Boeckh. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy , 1999, Transplant infectious disease : an official journal of the Transplantation Society.
[20] W. Hughes. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] E. Shpall,et al. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. , 1996, Kidney international.
[22] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[23] J. Gold,et al. Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.
[24] R. Zager,et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[26] R Storb,et al. Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.
[27] R Storb,et al. Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.
[28] C. García-Cantón,et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. , 1995, American journal of nephrology.
[29] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.